TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY TREATMENT TYPE (USD BILLION)
6.1. Medications
6.2. Dietary Supplements
6.3. Probiotics
6.4. Psychological Therapies
7. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY DRUG CLASS (USD BILLION)
7.1. Antispasmodics
7.2. Laxatives
7.3. Antidiarrheal Agents
7.4. Antidepressants
8. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
8.1. Oral
8.2. Injectable
8.3. Topical
9. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY PATIENT TYPE (USD BILLION)
9.1. Adult
9.2. Pediatric
10. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Irritable Bowel Syndrome (IBS) Treatment Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Irritable Bowel Syndrome (IBS) Treatment Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Takeda Pharmaceutical
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Sanofi
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Motif Bio
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. AbbVie
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Boehringer Ingelheim
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Sorrento Therapeutics
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Allergan
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. GlaxoSmithKline
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Progenity
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Johnson and Johnson
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Pfizer
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Roche
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Corcept Therapeutics
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Merck and Co
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. AstraZeneca
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 9. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 10. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 11. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 29. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 30. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 31. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 59. APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 60. APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 61. APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 129. MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 130. MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 131. MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY DRUG CLASS, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS
FIGURE 3. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 4. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 5. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 6. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 7. US IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 9. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 10. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 11. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 12. CANADA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS
FIGURE 14. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 15. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 16. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 17. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 18. GERMANY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 20. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 21. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 22. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 23. UK IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 25. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 26. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 27. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 28. FRANCE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 30. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 31. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 32. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 33. RUSSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 35. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 36. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 37. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 38. ITALY IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 40. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 41. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 42. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 43. SPAIN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 45. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 46. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 47. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 48. REST OF EUROPE IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS
FIGURE 50. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 51. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 52. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 53. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 54. CHINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 56. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 57. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 58. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 59. INDIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 61. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 62. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 63. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 64. JAPAN IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 66. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 67. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 68. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 69. SOUTH KOREA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 71. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 72. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 73. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 74. MALAYSIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 76. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 77. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 78. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 79. THAILAND IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 81. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 82. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 83. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 84. INDONESIA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 86. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 87. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 88. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 89. REST OF APAC IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS
FIGURE 91. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 92. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 93. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 94. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 95. BRAZIL IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 97. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 98. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 99. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 100. MEXICO IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 102. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 103. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 104. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 105. ARGENTINA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 107. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 108. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 109. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 110. REST OF SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 113. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 114. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 115. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 116. GCC COUNTRIES IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 118. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 119. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 120. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 121. SOUTH AFRICA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 123. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY DRUG CLASS
FIGURE 124. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 125. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY PATIENT TYPE
FIGURE 126. REST OF MEA IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET
FIGURE 133. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY TREATMENT TYPE, 2024 (% SHARE)
FIGURE 134. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY TREATMENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY DRUG CLASS, 2024 (% SHARE)
FIGURE 136. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY DRUG CLASS, 2019 TO 2032 (USD Billions)
FIGURE 137. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 138. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 139. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY PATIENT TYPE, 2024 (% SHARE)
FIGURE 140. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY PATIENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 141. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. IRRITABLE BOWEL SYNDROME (IBS) TREATMENT MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
